GLPwatch
The Lira Pump Trial
NCT02351232 · Completed
Last updated 2026-05-28This clinical trial is testing whether using an insulin pump with the medication liraglutide helps manage blood sugar levels in adults with type 1 diabetes.
Status Completed The study has finished.
Phase Phase2, Phase3
Type Interventional (clinical trial)
Design Randomized, quadruple-blind treatment study
Participants 44 people
Who can join Ages 18–70 · all sexes
Timeline Started 2015-02 · est. completion 2016-10
Where 2 sites · Denmark
What this study is testing ClinicalTrials.gov NCT02351232 ↗
Description as written by the study sponsor.
A randomized placebo-controlled clinical trial investigating the effects of Liraglutide as an add-on to intensive insulin therapy in overweight insulin pump treated type 1 diabetes patients in suboptimal glycemic control.
Treatments tested
- Liraglutide also known as Victoza Drug
- Placebo Drug
| Main thing measured | Change in HbA1c |
|---|---|
| Sponsor | Hvidovre University Hospital |
| Conditions studied | Type 1 Diabetes |
| GLP-1 drugs | — |
Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT02351232 ↗